RareCyte, Inc. Pashtoon Kasi MD, MS Amazing people, amazing results, this brings so much hope. Thank you everyone. I’ll keep making the positive music to listen to in the labs :) 🧡

Like a starry sky indeed!✨ Privileged to see the ongoing excellent work in the #NEST -1 trial.
Pashtoon Kasi MD, MS
#spatialbiology #orion #rarecyte

Fantastic discussion on biomarker testing and precison oncology - Rafeh Naqash, MD
OU Health Stephenson Cancer Center Ignacio Garrido-Laguna Sunnie Kim, MD Pashtoon Kasi MD, MS
oncodaily.com/50307.html

#Cancer #ColorectalCancer #OncoDaily #Oncology #PrecisonOncology

Pashtoon Kasi MD, MS RareCyte, Inc. Wow, these immune cells are like a fierce squad of warriors!

👇🏾💡Here’s a novel finding from our #NESTTrial 🪺.

Lymphocytes go⬇️in patients with MSS.
🚕🚕🚕 “Recruitment” from blood to go to where the action is (tumor).

Lymphocytes go⬆️in patients with MSI-High.
“Normalization”.

➕🆕🔢“Kasi” formula 2.0➡️MSI from a simple CBC using NLR.

BOT/BAL we are at our 12+ patients with MSS colorectal cancer within weeks - Pashtoon Kasi MD, MS
Weill Cornell Medicine

#Cancer #ColorectalCancer #ClinicalTrials #OncoDaily #Oncology #NeoadjuvantImmunotherapy

oncodaily.com/47926.html

$AGEN (NP)

Pashtoon Kasi MD, MS RareCyte, Inc. That’s quite a leap

Fantastic discussion on biomarker testing and precison oncology . GI cancer discussion now led by Ignacio Garrido-Laguna Sunnie Kim, MD and talking about Pashtoon Kasi MD, MS trial in MSS CRC with ICI!

This starry sky is what the immune cells look like gathering around a cancer that’s getting killed - Pashtoon Kasi MD, MS

#Cancer #Cancer Cell #NESTTrial #OncoDaily #Oncology

oncodaily.com/48672.html

Pashtoon Kasi MD, MS FDA Oncology OncoAlert That sounds like a good thing! Any idea when CRC will use the same policy? Why aren’t all trials for all cancer types using this?

Sanjay Patel, MD Pashtoon Kasi MD, MS RareCyte, Inc. X playing matchmaker 🥰👏

Pashtoon Kasi MD, MS RareCyte, Inc. Pashtoon, we'd love to support your trial work through our MISI Lab in the Dept of Pathology: pathology.weill.cornell.edu/divisions/mult…

This starry sky🌈🌌 is what the immune cells look like gathering around a cancer that’s getting killed.

What’s fascinating is the diversity and crosstalk. The focus on one type of cell is an oversimplification.

BOT diversifies➕BAL maintains.
#NEST -1 🪺trial

📸RareCyte, Inc. #CRCSM

We have some incredible news.🗞️
#NEST -2 🪺 BOT/BAL we are at our 12+ patients with MSS #ColorectalCancer within weeks!

Further expansion approved🙌🏾.

💡Cohorts:
🟢MSS Colon n=77
🔵➕a 🆕 MSS Rectal cohort n=30
🔴MSI-H n=15

🏃‍♂️with this story! OncoAlert

nyp.org/advances/artic…

Pashtoon Kasi MD, MS OncoAlert Colorectal Cancer Alliance Fight Colorectal Cancer COLONTOWN Enlightening Results 💡 Mark Lewis Vivek Subbiah, MD gilberto lopes Michael Sapienza Mike Thompson, MD, PhD, FASCO WCM Englander Institute for Precision Medicine Congrats Dr. Kasi! It's wonderful to see all the progress in treating #colorectalcancer !

Tim Willson Pashtoon Kasi MD, MS *it’s not too soon to be sure. This story is going to be a tidal wave when it finally breaks out into the broader public.

Adam N Pashtoon Kasi MD, MS Confidence in the combo is strong and growing, but there are regulatory and financial hurdles still ahead and we can’t be presumptuous about those details. Biotech is such a long, tough road compared to many other industries (even when cancer patients are waiting for help).